Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naftazone in Advanced Parkinson's Disease
NCT02641054Phase 2Completed
- Sponsor
- CleveXel Pharma
- Start
- Feb 2016
- Primary completion
- Jun 2017
- Countries
- 1
01
Overview
A Phase 2 trial of naftazone in Parkinson's disease (PD), levodopa-induced dyskinesia (LID), sponsored by CleveXel Pharma. Started Feb 2016; status: completed.
02
Drugs
naftazone
03
Conditions
Parkinson's disease (PD)levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT02641054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02641054.